The AKT1 gene is associated with attention and brain morphology in schizophrenia
暂无分享,去创建一个
Takashi Morihara | Masao Iwase | Takashi Kudo | Hiroaki Kazui | Hidetoshi Takahashi | Kiyotaka Nemoto | Masatoshi Takeda | Takashi Ohnishi | Koji Ikezawa | Michiyo Azechi | Tetsuhiko Yoshida | Hidenaga Yamamori | Yuka Yasuda | Ryota Hashimoto | T. Ohnishi | T. Kudo | H. Kazui | K. Ohi | R. Hashimoto | M. Iwase | Hidetoshi Takahashi | M. Takeda | H. Yamamori | Toshihisa Tanaka | T. Morihara | S. Tagami | M. Okochi | K. Nemoto | Y. Yasuda | K. Ikezawa | M. Azechi | H. Tanimukai | Kazutaka Ohi | N. Iike | Tetsuhiko Yoshida | Motoyuki Fukumoto | Naomi Iike | Hitoshi Tanimukai | Shinji Tagami | Masayasu Okochi | Toshihisa Tanaka | M. Fukumoto | Kouzin Kamino | K. Kamino
[1] T. Arinami,et al. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case–control population , 2004, Molecular Psychiatry.
[2] B. Kolachana,et al. Epistatic and Functional Interactions of Catechol-O-Methyltransferase (COMT) and AKT1 on Neuregulin1-ErbB Signaling in Cell Models , 2010, PloS one.
[3] T. Asada,et al. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia , 2006, Journal of neurochemistry.
[4] U. Kang,et al. The effects of clozapine on the GSK‐3‐mediated signaling pathway , 2004, FEBS letters.
[5] M. Ikeda,et al. Association of AKT1 with schizophrenia confirmed in a Japanese population , 2004, Biological Psychiatry.
[6] D. Weinberger,et al. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia , 2007, Molecular Psychiatry.
[7] Yusuke Nakamura,et al. Case–control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population , 2009, Journal of Human Genetics.
[8] J. Callicott,et al. Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? , 2008, Molecular Psychiatry.
[9] M. Egan,et al. Verbal and visual memory: Characterizing the clinical and intermediate phenotype in schizophrenia , 2008, Schizophrenia Research.
[10] W. Maier,et al. Further Evidence for Association of Variants in the AKT1 Gene with Schizophrenia in a Sample of European Sib-Pair Families , 2005, Biological Psychiatry.
[11] M. Egan,et al. Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.
[12] E. Bullmore,et al. Anatomy of bipolar disorder and schizophrenia: A meta-analysis , 2010, Schizophrenia Research.
[13] Takahisa Taguchi,et al. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. , 2006, Human molecular genetics.
[14] R. Gainetdinov,et al. The Akt-GSK-3 signaling cascade in the actions of dopamine. , 2007, Trends in pharmacological sciences.
[15] P. Pavlidis,et al. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning , 2006, Proceedings of the National Academy of Sciences.
[16] T. Robbins,et al. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. , 1997, Brain : a journal of neurology.
[17] I. Gottesman,et al. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. , 2000, American journal of medical genetics.
[18] Zhongming Zhao,et al. Candidate genes for schizophrenia: A survey of association studies and gene ranking , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[19] I. Lucki,et al. Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function , 2012, Hippocampus.
[20] Carles Falcón,et al. Decreased cerebral activation during CPT performance structural and functional deficits in schizophrenic patients , 2004, NeuroImage.
[21] Jianxin Shi,et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. , 2008, The American journal of psychiatry.
[22] A. Levine,et al. Detection of functional single-nucleotide polymorphisms that affect apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Jope,et al. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling , 2001, Progress in Neurobiology.
[24] M. Tsuang. Schizophrenia: genes and environment , 2000, Biological Psychiatry.
[25] A. Meyer-Lindenberg,et al. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. , 2008, The Journal of clinical investigation.
[26] Jing Wang,et al. Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. , 2008, Learning & memory.
[27] M. Leboyer,et al. Association of AKT1 gene variants and protein expression in both schizophrenia and bipolar disorder , 2010, Genes, brain, and behavior.
[28] G. Blasi,et al. DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia , 2010, Proceedings of the National Academy of Sciences.
[29] Tyrone D. Cannon,et al. Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[30] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[31] Elliot S. Gershon,et al. Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes , 2008, Schizophrenia Research.
[32] O. Pietiläinen,et al. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland , 2007, Schizophrenia Research.
[33] P. Gean,et al. A Role for the PI-3 Kinase Signaling Pathway in Fear Conditioning and Synaptic Plasticity in the Amygdala , 2001, Neuron.
[34] S. Davis,et al. Signalling mechanisms mediated by the phosphoinositide 3‐kinase/Akt cascade in synaptic plasticity and memory in the rat , 2006, The European journal of neuroscience.
[35] Q. Gong,et al. Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. , 2011, Schizophrenia bulletin.
[36] Y. Ahn,et al. No association between AKT1 polymorphism and schizophrenia: A case–control study in a Korean population and a meta-analysis , 2010, Neuroscience Research.
[37] Sheng Li,et al. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. , 2007, The Journal of clinical psychiatry.
[38] D. Shaw,et al. Genetic association of the AKT1 gene with schizophrenia in a British population , 2010, Psychiatric genetics.
[39] A. Meyer-Lindenberg,et al. Intermediate phenotypes and genetic mechanisms of psychiatric disorders , 2006, Nature Reviews Neuroscience.
[40] J. Lieberman,et al. AKT1 and Neurocognition in Schizophrenia , 2007, The Australian and New Zealand journal of psychiatry.
[41] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[42] S. Faraone,et al. Sustained attention deficits as markers of genetic susceptibility to schizophrenia. , 2000, American journal of medical genetics.
[43] B. Cornblatt,et al. Impaired attention, genetics, and the pathophysiology of schizophrenia. , 1994, Schizophrenia bulletin.
[44] T. Nabeshima,et al. Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation , 2003, Molecular Psychiatry.
[45] Barbara A. Cornblatt,et al. The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients , 1989, Psychiatry Research.
[46] Michael F. Green,et al. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. , 2006, The Journal of clinical psychiatry.
[47] Vladimir I. Vladimirov,et al. AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families , 2008, Biological Psychiatry.
[48] A. Green,et al. Comorbid schizophrenia and substance abuse. , 2006, The Journal of clinical psychiatry.
[49] Cameron S Carter,et al. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. , 2005, Schizophrenia bulletin.
[50] T. Sotnikova,et al. Regulation of Akt Signaling by D2 and D3 Dopamine Receptors In Vivo , 2007, The Journal of Neuroscience.
[51] M. R. Sargolzaee,et al. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[52] S. Faraone,et al. Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population , 2006, Psychiatric genetics.
[53] Leonardo Fazio,et al. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory , 2007, Proceedings of the National Academy of Sciences.
[54] B. Cornblatt,et al. The continuous performance test, identical pairs version (CPT-IP) : III: Brain functioning during performance of numbers and shapes subtasks , 1997, Psychiatry Research: Neuroimaging.
[55] F. McMahon,et al. Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling , 2011, The Pharmacogenomics Journal.
[56] G. E. Alexander,et al. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.
[57] T. Sotnikova,et al. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[58] M. Owen,et al. Association analysis of AKT1 and schizophrenia in a UK case control sample , 2007, Schizophrenia Research.
[59] M. Karayiorgou,et al. Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia , 2004, Nature Genetics.
[60] J. Javitch,et al. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. , 2010, The American journal of psychiatry.
[61] Norio Ozaki,et al. Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia. , 2008, Pharmacogenomics.
[62] T. Sotnikova,et al. An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior , 2005, Cell.